Abstract

We report the results of a quantum chemical investigation of the 31P nuclear magnetic resonance (NMR) isotropic chemical shieldings (σiso) and the 31P NMR chemical shielding tensor principal values (σii, i = 1−3) in a series of eight different phosphonates, including the bisphosphonates pamidronate and risedronate currently in use in bone resorption therapy. We used primarily Hartree−Fock methods with a 6-311++G(2d,2p) basis set and the CSGT (continuous set of gauge transformations) formalism to predict the experimental observables, using various approaches to incorporating intermolecular, crystal lattice effects. Good predictions of the 31P NMR isotropic chemical shielding, shielding tensor principal values, and tensor orientations were obtained, with R2 = 0.95 and ∼7% root-mean-square error from experiment. In the zwitterionic aminophosphonates, electrostatic (lattice) interactions were found to be strong but could be well accounted for by incorporating charge lattice effects into the calculations. The ability to now predict both isotropic and anisotropic shielding (shift) tensors in phosphonates and bisphosphonates should open the way to the determination of their protonation states when bound to proteins, information which is not accessible from crystallographic studies.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.